NO953770D0 - Analysemetode - Google Patents

Analysemetode

Info

Publication number
NO953770D0
NO953770D0 NO953770A NO953770A NO953770D0 NO 953770 D0 NO953770 D0 NO 953770D0 NO 953770 A NO953770 A NO 953770A NO 953770 A NO953770 A NO 953770A NO 953770 D0 NO953770 D0 NO 953770D0
Authority
NO
Norway
Prior art keywords
pct
sec
date
analysis method
human
Prior art date
Application number
NO953770A
Other languages
English (en)
Norwegian (no)
Other versions
NO953770L (no
Inventor
Nils Olav Solum
Frank Brosstad
Paal Andre Holme
Geir Olav Gogstad
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO953770(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO953770L publication Critical patent/NO953770L/no
Publication of NO953770D0 publication Critical patent/NO953770D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Telephone Function (AREA)
  • Medicinal Preparation (AREA)
NO953770A 1993-03-24 1995-09-22 Analysemetode NO953770D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306053A GB9306053D0 (en) 1993-03-24 1993-03-24 Method and assay
PCT/GB1994/000592 WO1994022018A1 (en) 1993-03-24 1994-03-23 Method and assay

Publications (2)

Publication Number Publication Date
NO953770L NO953770L (no) 1995-09-22
NO953770D0 true NO953770D0 (no) 1995-09-22

Family

ID=10732620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953770A NO953770D0 (no) 1993-03-24 1995-09-22 Analysemetode

Country Status (13)

Country Link
US (1) US5811250A (de)
EP (1) EP0694168B2 (de)
JP (1) JP3422491B2 (de)
AT (1) ATE154847T1 (de)
AU (1) AU691489B2 (de)
CA (1) CA2158363C (de)
DE (1) DE69403961T3 (de)
DK (1) DK0694168T4 (de)
ES (1) ES2103582T5 (de)
FI (1) FI113206B (de)
GB (1) GB9306053D0 (de)
NO (1) NO953770D0 (de)
WO (1) WO1994022018A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
NO20031431D0 (no) * 2003-03-28 2003-03-28 Forskningsparken As Metode for å diagnostisere hemostatiske forstyrrelser ved bruk av mikrovesikler fra blodplater
ES2571929T3 (es) * 2004-05-26 2016-05-27 Region Nordjylland Procedimiento para determinar la cantidad de CD36 circulante
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
EP2069528B1 (de) * 2007-02-05 2013-03-27 Region Nordjylland Verfahren zur diagnostizierung atherosklerotischer plaque durch messung von cd36
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
KR101810799B1 (ko) * 2008-02-01 2017-12-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
IT1398680B1 (it) * 2009-06-12 2013-03-08 Bios Internat S R L Metodo in vitro per la determinazione della proteina gp91phox come marker di stress ossidativo
US20130029339A1 (en) 2009-09-09 2013-01-31 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
EP2475988B1 (de) 2009-09-09 2018-11-14 The General Hospital Corporation Verwendung von mikrovesikeln bei der analyse von nukleinsäureprofilen
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
WO2011084791A2 (en) 2009-12-21 2011-07-14 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-vegf treatment
EP2542696B1 (de) 2010-03-01 2016-09-28 Caris Life Sciences Switzerland Holdings GmbH Theranostik-biomarker
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
CA2817111C (en) 2010-11-10 2019-03-05 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities

Also Published As

Publication number Publication date
ATE154847T1 (de) 1997-07-15
GB9306053D0 (en) 1993-05-12
EP0694168B2 (de) 2002-06-12
WO1994022018A1 (en) 1994-09-29
JP3422491B2 (ja) 2003-06-30
AU6262794A (en) 1994-10-11
DE69403961T2 (de) 1998-01-02
NO953770L (no) 1995-09-22
DE69403961T3 (de) 2003-01-16
DE69403961D1 (de) 1997-07-31
AU691489B2 (en) 1998-05-21
FI954499A0 (fi) 1995-09-22
ES2103582T5 (es) 2002-12-16
FI113206B (fi) 2004-03-15
US5811250A (en) 1998-09-22
DK0694168T4 (da) 2002-09-30
CA2158363A1 (en) 1994-09-29
FI954499L (fi) 1995-09-22
EP0694168A1 (de) 1996-01-31
ES2103582T3 (es) 1997-09-16
EP0694168B1 (de) 1997-06-25
JPH08509806A (ja) 1996-10-15
DK0694168T3 (da) 1997-07-21
CA2158363C (en) 2004-08-17

Similar Documents

Publication Publication Date Title
NO953770D0 (no) Analysemetode
DE3064061D1 (en) Test piece for measuring glucose
DE3851958D1 (de) VERFAHREN UND VORRICHTUNG ZUR BEHANDLUNG VON KöRPERLICHEN FLÜSSIGKEITEN.
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
NO950594D0 (no) Fremgangsmåte for diagnostisering og overvåking av sepsis
ATE245810T1 (de) Probenentnahmevorrichtung
HU9203127D0 (en) Diagnostical method carrier out using supermagnetic particles and paramagnetic materials as contrast agents
GR3033138T3 (en) Process and compounds for the magnetorelaxometric detection of analytes and use thereof
NO890071D0 (no) Nedbrytningsanalyse for kollagen type iii.
GR3031488T3 (en) Laminin chains: diagnostic and therapeutic use
ATE213333T1 (de) Überwachungsverfahren
ATE224672T1 (de) Anordnung zur kontinuierlichen messung des herzminutenvolumens
DE59705193D1 (de) Ventil für flüssigkeiten
DK0791073T3 (da) Analysemetode
ES2126151T3 (es) Metodo para cuantificar bpi extracelular en fluidos corporales.
ATE136940T1 (de) Diagnostische methode
DE3863188D1 (de) Mittel zur eliminierung von chloramin.
FR2825247B1 (fr) Dispositif de conditionnement et/ou d'application contenant des fibres comportant au moins un corps aimante ou aimantable
DE59409704D1 (de) In den menschlichen körper einführbares instrument
DE69319127D1 (de) Konjugat für den Nachweis und/oder Quantifizierung von biologischen Komponenten
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
RU94038422A (ru) Способ оценки эффективности лечения атопического дерматита у детей
DE69423796D1 (de) Testverfahren und Reagenz für Magnesium in menschlichen Körperflüssigkeiten
Jacobs et al. Treatment-outcome interactions
UA28749A (uk) Спосіб оцінки ефективності лікування гіпертонічної хвороби